Literature DB >> 8845296

Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells.

D Agrawal1, F Dong, Y Z Wang, D Kayda, W J Pledger.   

Abstract

We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells. Cell populations stimulated to undergo cell cycle traverse displayed little change in the level of cyclin E, while p27kip was found to be reduced 50-80% in proliferating cells. Analysis of mitotic cells, however, revealed that cyclin E is virtually absent and begins to reaccumulate soon after mitosis is complete, as does p27kip. Immunoprecipitation experiments revealed that p27kip is associated with cyclin E in quiescent but not proliferating cells, indicating that it may function to prevent development of cyclin E activity in the absence of growth factors. Based on our characterization of cyclin E and p27kip in BALB/c 3T3 cells during progression of the cell cycle, we propose a model of growth regulation controlling the G1 phase of growing and quiescent cells involving mitotic degradation of cyclin E and recovery of p27kip inhibitory activity in a late or postmitotic interval.

Mesh:

Substances:

Year:  1995        PMID: 8845296

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells.

Authors:  D Agrawal; P Hauser; F McPherson; F Dong; A Garcia; W J Pledger
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

2.  Adenovirus E1A-regulated transcription factor p120E4F inhibits cell growth and induces the stabilization of the cdk inhibitor p21WAF1.

Authors:  E R Fernandes; J Y Zhang; R J Rooney
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

3.  Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1).

Authors:  X Zhang; W Wharton; M Donovan; D Coppola; R Croxton; W D Cress; W J Pledger
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

4.  The physiology and pathophysiology of rapamycin resistance: implications for cancer.

Authors:  Philip A Gruppuso; Joan M Boylan; Jennifer A Sanders
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

5.  Human glioma PKC-iota and PKC-betaII phosphorylate cyclin-dependent kinase activating kinase during the cell cycle.

Authors:  M Acevedo-Duncan; R Patel; S Whelan; E Bicaku
Journal:  Cell Prolif       Date:  2002-02       Impact factor: 6.831

6.  Involvement of PKC-iota in glioma proliferation.

Authors:  R Patel; H Win; S Desai; K Patel; J A Matthews; M Acevedo-Duncan
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

7.  Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells.

Authors:  F Dong; D Agrawal; T Bagui; W J Pledger
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

8.  Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4+ T-cell lines.

Authors:  Melissa A Lang; Sultan A Jenkins; Phillip Balzano; Adeyinka Owoyele; Akshay Patel; Anil K Bamezai
Journal:  Immun Inflamm Dis       Date:  2017-06-28

9.  DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.

Authors:  Rebeca Carrión-Marchante; Valerio Frezza; Ana Salgado-Figueroa; M Isabel Pérez-Morgado; M Elena Martín; Víctor M González
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

10.  Human VRK1 is an early response gene and its loss causes a block in cell cycle progression.

Authors:  Alberto Valbuena; Inmaculada López-Sánchez; Pedro A Lazo
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.